Cancer risks associated with the diagnosis of infertility

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 17, Issue 2, 2003, Pages 343-367

  Venn, Alison ^a   Healy, David ^b   McLachlan, Robert ^c  

^a UNIVERSITY OF TASMANIA   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

^c HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Cancer; Childhood cancer; Female infertility; Fertility drugs; Male infertility

Indexed keywords

CLOMIFENE CITRATE; DIETHYLSTILBESTROL; ESTROGEN DERIVATIVE; FERTILITY PROMOTING AGENT; HUMAN MENOPAUSAL GONADOTROPIN; ORAL CONTRACEPTIVE AGENT; SEX HORMONE;

BREAST CANCER; CANCER; CANCER INCIDENCE; CANCER INVASION; CANCER RISK; CHILDHOOD CANCER; COMMUNITY CARE; DISEASE ASSOCIATION; DRUG SAFETY; ESTROGEN THERAPY; FEMALE; FEMALE FERTILITY; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GYNECOLOGIC CANCER; HUMAN; INFERTILITY; MALE; MALE FERTILITY; MALE INFERTILITY; NEUROBLASTOMA; OVARY CANCER; OVARY INSUFFICIENCY; OVARY TUMOR; PATIENT INFORMATION; PRIORITY JOURNAL; REVIEW; TESTIS CANCER; UTERUS CANCER;

EID: 0038780433     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6934(02)00128-1     Document Type: Review

References (72)

1. Rosen B, Irvine J, Ritvo P et al. The feasibility of assessing women's perceptions of the risks and benefits of fertility drug therapy in relation to ovarian cancer risk. Fertility and Sterility 1997; 68: 90-94.
2. Stewart DE, Rosen B, Irvine J et al. The disconnect: Infertility patients' information and the role they wish to play in decision making. Medscape Womens Health 2001; 6: 1.
3. Healy D & Petrucco O. Effective Gynecological Day Surgery. London: Chapman and Hall Medical, 1998.
4. National Health and Medical Research Council and Australian Institute of Health and Welfare, Report on Maternal Deaths in Australia, 1994-1996. Canberra: NHMRC and AIHW, 2001.
5. National Perinatal Statistics Unit, Congenital Malformations, Australia, 1981-1997. Series 4e, Electronic Version only, Sydney, Australia: NPSU, 2001. http://www.aihw.gov.au/npsu/cm97.pdf
6. Maclennan A. The origins of cerebral palsy - A consensus statement. The Australian and New Zealand Perinatal Societies. Medical Journal of Australia 1995; 162: 86-91.
7. Glud E, Kjaer SK, Troisi R & Brinton L. Fertility drugs and ovarian cancer. Epidemiologic Reviews 1998; 20: 237-257.
8. Klip H, Burger CW, Kenemans P & Van Leeuwen FE. Cancer risk associated with subfertility and ovulation induction. Cancer Causes and Control 2001; 11: 319-344.
9. Collaborative Group on Hormonal Factors in Breast Cancer, Breast cancer and hormonal contraceptives: Collaborative re-analysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet 1996; 347: 1713-1727.
10. Collaborative Group on Hormonal Factors in Breast Cancer, Breast cancer and hormone replacement therapy: Collaborative re-analysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer. Lancet 1997; 350: 1047-1059.
11. Rossing MA, Daling JR, Weiss NS, Moore DE & Self SG. Ovarian tumors in a cohort of infertile women. New England Journal of Medicine 1994; 331: 771-776.
12. Venn A, Watson L, Bruinsma F, Giles G & Healy D. Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet 1999; 354: 1586-1590.
13. Klip H, Burger CW, De Kraker J & Van Leeuwen FE. Risk of cancer in the offspring of women who underwent ovarian stimulation for IVF. European Society of Human Reproduction and Embryology 2001; 16: 2451-2458.
14. Modan B, Ron E, Lerner-Geva L et al. Cancer incidence in a cohort of infertile women. American Journal of Epidemiology 1998; 147: 1038-1042.
15. Garland M, Hunter DJ, Colditz GA et al. Menstrual cycle characteristics and history of ovulation infertility in relation to breast cancer risk in a large cohort of US women. American Journal of Epidemiology 1998; 147: 636-642.
16. Whittemore A, Harris R, Itnyre J & The Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. American Journal of Epidemiology 1992; 136: 1184-1203.
17. Ness RB, Cramer DW, Goodman MT et al. Infertility, fertility drugs, and ovarian cancer: A pooled analysis of case-control studies. American Journal of Epidemiology 2002; 155: 217-224.
18. Dwyer T, Couper D & Walter S. Sources of heterogeneity in the meta-analysis of observational studies. The example of SIDS and sleeping position. Journal of Clinical Epidemiology 2001; 54: 440-447.
19. Rodriguez C, Tatham LM, Calle EE et al. Infertility and risk of fatal ovarian cancer in a prospective cohort of US women. Cancer Causes and Control 1998; 9: 645-651.
20. Parazzini F, Pelucchi C, Negri E et al. Use of fertility drugs and risk of ovarian cancer. Human Reproduction 2001; 16: 1372-1375.
21. Schildkraut JM, Schwingl PJ, Bastos E, Evanoff A & Hughes C. Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstetrics and Gynecology 1996; 88: 554-559.
22. Brinton LA, Gridley G, Persson I, Baron J & Bergqvist A. Cancer risk after a hospital discharge diagnosis of endometriosis. American Journal of Obstetrics and Gynecology 1997; 176: 572-579.
23. Ron E, Lunenfeld B, Menczer J et al. Cancer incidence in a cohort of infertile women. American Journal of Epidemiology 1987; 125: 780-790.
24. Harris R, Whittemore A, Itnyre J & The Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. III Epithelial tumors of low malignant potential. American Journal of Epidemiology 1992; 136: 1204-1211.
25. Mosgaard BJ, Lidegaard Ø, Kjaer SK, Schou G & Andersen AN. Ovarian stimulation and borderline ovarian tumors: A case-control study. Fertility and Sterility 1998; 70: 1049-1055.
26. Harlow BL, Weiss NS, Roth GS, Chu J & Daling JR. Case-control study of borderline ovarian tumors: Reproductive history and exposure to exogenous female hormones. Cancer Research 1988; 48: 5849-5852.
27. Gammon MD & Thompson WD. Polycystic ovaries and the risk of breast cancer. American Journal of Epidemiology 1991; 134: 818-824.
28. Anderson KE, Sellers TA, Chen P-L et al. Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa. Cancer 1997; 79: 494-499.
29. Parazzini F, Franceschi S, La Vecchia C & Fasoli M. The epidemiology of ovarian cancer. Gynecologic Oncology 1991; 43: 9-23.
30. Rossing M, Daling J, Weiss N, Moore D & Self S. In situ and invasive cervical carcinoma in a cohort of infertile women. Fertility and Sterility 1996; 65: 19-22.
31. Venn A, Watson L, Lumley J et al. Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet 1995; 346: 995-1000.
32. Rossing M, Daling J, Weiss N, Moore D & Self S. Risk of cutaneous melanoma in a cohort of infertile women. Melanoma Research 1995; 5: 123-127.
33. Young P, Purdie D, Jackman L, Molloy D & Green A. A study of infertility treatment and melanoma. Melanoma Research 2001; 11: 535-541.
34. Potashnik G, Lerner-Geva L, Genkin L et al. Fertility drugs and the risk of breast and ovarian cancers: Results of a long-term follow-up study. Fertility and Sterility 1999; 71: 853-859.
35. Shushan A, Paltiel O, Iscovich J et al. Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertility and Sterility 1996; 65: 13-18.
36. Harlow BL, Weiss NS & Lofton S. Epidemiology of borderline ovarian tumors. Journal of the National Cancer Institute 1987; 78: 71-74.
37. Braga C, Negri E, La Vecchia C et al. Fertility treatment and the risk of breast cancer. Human Reproduction 1996; 11: 300-303.
38. Rossing M, Daling J, Weiss N, Moore D & Self S. Risk of breast cancer in a cohort of infertile women. Gynecologic Oncology 1996; 60: 3-7.
39. De Krester DM & Baker HW. Infertility in men: Recent advances and continuing controversies. Journal of Clinical Endocrinology and Metabolism 1999; 84: 3443-3450.
40. Boisen KA, Main KM, Rajpert-De ME & Shakkebæk NE. Are male reproductive disorders a common entity? The testicular dysgenesis syndrome. Annals of the New York Academy of Science 2001; 948: 90-99.
41. Skakkebæ NE, Rajpert-De ME & Main KM. Testicular dysgenesis syndrome: An increasingly common developmental disorder with environmental aspects. Human Reproduction 2001; 16: 972-978.
42. Skakkebæk NE, Rajpert-De ME & Toppari J. Cancer pathogenesis, diagnosis and endocrine aspects. 2002. http://www.ENDOTEXT.org.
43. Moss AR, Osmond D, Bacchetti P et al. Hormonal risk factors in testicular cancer. A case-control study. American Journal of Epidemiology 1986; 124: 39-52.
44. Depue RH, Pike MC & Henderson BE. Estrogen exposure during gestation and risk of testicular cancer. Journal of the National Cancer Institute 1983; 71: 1151-1155.
45. Weir HK, Marrett LD, Kreiger N, Darlington GA & Sugar L. Pre-natal and peri-natal exposures and risk of testicular germ-cell cancer. International Journal of Cancer 2000; 87: 438-443.
46. Giwercman A, Grindsted J, Hansen B, Jensen OM & Skakkebæk NE. Testicular cancer risk in boys with maldescended testis: A cohort study. Journal of Urology 1987; 138: 1214-1216.
47. United Kingdom Testicular Cancer Study Group, Aetiology of testicular cancer: Association with congenital abnormalities, age at puberty, infertility, and exercise. British Medical Journal 1994; 308: 1393-1399.
48. Engeler DS, Hosli PO, John H et al. Early orchidopexy: Prepubertal intratubular germ cell neoplasia and fertility outcome. Urology 2000; 56: 144-148.
49. Leary FJ, Resseguie LJ, Kurland LT et al. Males exposed in utero to diethylstilbestrol. Journal of the American Medical Association 1984; 252: 2984-2989.
50. Strohsnitter WC, Noller KL, Hoover RN et al. Cancer risk in men exposed in utero to diethylstilbestrol. Journal of the National Cancer Institute 2001; 93: 545-551.
51. Jacobsen R, Bostofte E, Engholm G et al. Fertility and offspring sex ratio of men who develop testicular cancer: A record linkage study. Human Reproduction 2000; 15: 1958-1961.
52. Møller H & Shakkebæk NE. Risk of testicular cancer in subfertile men: Case-control study. British Medical Journal 1999; 318: 559-562.
53. Jacobsen R, Bostofte E, Engholm G et al. Risk of testicular cancer in men with abnormal semen characteristics: Cohort study. British Medical Journal 2000; 321: 789-792.
54. Berthelsen JG & Shakkebæk NE. Gonadal function in men with testis cancer. Fertility and Sterility 1983; 39: 68-75.
55. Harland SJ, Cook PA, Fossa SD et al. Intratubular germ cell neoplasia of the contralateral testis in testicular cancer: Defining a high risk group. Journal of Urology 1987; 160: 1353-1357.
56. Bettocchi C, Coker CB, Deacon J, Parkinson C & Pryor JP. A review of testicular intratubular germ cell neoplasia in infertile men. Journal of Andrology 1994; 15(supplement): 14S-16S.
57. Giwercman A, Thomsen JK, Hertz J et al. Prevalence of carcinoma in situ of the testis in 207 oligozoospermic men from infertile couples: Prospective study of testicular biopsies. British Medical Journal 1997; 315: 989-991.
58. Kramer S, Ward E & Meadows A. Medical and drug risk factors associated with neuroblastoma: A case-control study. Journal of the National Cancer Institute 1987; 78: 797-804.
59. Michalek A, Buck G & Nasca P. Gravid health status, medication use and risk of neuroblastoma. American Journal of Epidemiology 1996; 143: 996-1001.
60. Olshan AF, Smith J, Cook MN et al. Hormone and fertility drug use and the risk of neuroblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group. American Journal of Epidemiology 1999; 150: 930-938.
61. Cowan LD, Gordis L, Tonascia JA & Jones GS. Breast cancer incidence in women with a history of progesterone deficiency. American Journal of Epidemiology 1981; 114: 209-217.
62. Brinton L, Melton J, Malkasian G, Bond A & Hoover R. Cancer risk after evaluation for infertility. American Journal of Epidemiology 1989; 129: 712-722.
63. Lé MG, Bachelot A & Hill C. Characteristics of reproductive life and risk of breast cancer in a case-control study of young nulliparous women. Journal of Clinical Epidemiology 1989; 42: 1227-1233.
64. Gammon MD & Thompson WD. Infertility and breast cancer: A population-based case-control study. American Journal of Epidemiology 1990; 132: 708-716.
65. Moseson M, Koenig KL, Shore RE & Pasternack BS. The influence of medical conditions associated with hormones on the risk of breast cancer. International Journal of Epidemiology 1993; 22(6): 1000-1009.
66. Dor J, Lerner-Geva L, Rabinovici J et al. Cancer incidence in a cohort of infertile women who underwent in vitro fertilization. Fertility and Sterility 2002; 77: 324-327.
67. Ricci E, Parrazini F, Negri E, Marsico S & La Vecchia C. Fertility drugs and the risk of breast cancer. Human Reproduction 1999; 14: 1653-1655.
68. Henderson BE, Benton B, Jing J, Yu MC & Pike MC. Risk factors for cancer of the testis in young men. International Journal of Cancer 1979; 23: 598-602.
69. Swerdlow AJ, Huttly SRA & Smith PG. Testis cancer: Post-natal hormonal factors, sexual behaviour and fertility. International Journal of Cancer 1989; 43: 549-553.
70. Doyle P, Bunch K, Beral V & Draper G. Cancer incidence in children conceived with assisted reproduction technology. Lancet 1998; 352: 452-453.
71. Bergh T, Ericson A, Hillensjo T, Nygren K-G & Wennerholm U-B. Deliveries and children born after in-vitro fertilisation in Sweden 1982-95: A retrospective cohort study. Lancet 1999; 354: 1579-1585.
72. Bruinsma F, Venn A, Lancaster P, Speirs A & Healy D. Incidence of cancer in children born after in-vitro fertilization. Human Reproduction 2000; 15: 604-607.